Marshall Wace North America’s Loxo Oncology, Inc LOXO Stock Holding History

Marshall Wace North America’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-193,114	Closed	-$27M	–	2097
2018 Q4	$27M	Buy	193,114 +38,277	+25%	+$5.81M	0.26%	87
2018 Q3	$26.5M	Sell	154,837 -152,972	-50%	-$25.7M	0.18%	121
2018 Q2	$53.4M	Buy	+307,809	New	+$46.3M	0.3%	76
2018 Q1	–	Sell	-79,182	Closed	-$6.67M	–	1838
2017 Q4	$6.67M	Sell	79,182 -59,087	-43%	-$4.93M	0.04%	494
2017 Q3	$12.7M	Sell	138,269 -278,569	-67%	-$21.6M	0.08%	310
2017 Q2	$33.3M	Buy	+416,838	New	+$23.1M	0.24%	100

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Marshall Wace North America's LOXO Position: Q1 2019 in Review

Marshall Wace North America sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 193,114 shares — an estimated $27M sold.

Marshall Wace North America first reported a position in LOXO in Q2 2017 and held it in 6 quarters. The position peaked at $53.4M in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Marshall Wace North America reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Marshall Wace North America sold 193,114 Loxo Oncology, Inc shares in Q1 2019, an estimated $27M.
Marshall Wace North America first reported a position in Loxo Oncology, Inc in Q2 2017 and held it in 6 quarters.
Marshall Wace North America's Loxo Oncology, Inc position peaked at $53.4M in Q2 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Marshall Wace North America's 13F filing for Q1 2019, filed 14 May 2019.